IAI MMBR Online 2003
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 21 April 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Cho, K. H.
Right arrow Articles by Caparon, M. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, K. H.
Right arrow Articles by Caparon, M. G.
Infect. Immun. doi:10.1128/IAI.01721-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

tRNA Modification by GidA/MnmE is Necessary for Streptococcus pyogenes Virulence: a New Strategy to Make Live Attenuated Strains

Kyu Hong Cho and Michael G. Caparon*

Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110-1093

* To whom correspondence should be addressed. Email: caparon{at}borcim.wustl.edu.


   Abstract

Studies directed at vaccine development and mucosal immunity against Streptococcus pyogenes would benefit from the availability of live attenuated strains. Our approach for production of candidate live attenuated strains was to identify mutations that did not alter growth in vitro, did not alter the overall complement of virulence factors produced, but did result in reduced levels of expression of multiple secreted virulence factors. A global reduction but not elimination of expression would likely lead to attenuation while maximizing the number of antigenic targets available for stimulation of immunity. Adaptation of Tn5-based transposome mutagenesis to S. pyogenes with initial screening for reduced expression of the SpeB protease, resulted in the identification of mutations in gidA, which encodes an enzyme involved in tRNA modification. Reduced SpeB expression was due to delayed onset of speB transcription resulting from reduced translation efficiency of the message for RopB, a transcriptional activator. Overall, GidA- mutants had a near-normal global transcription profile, but expressed significantly reduced levels of multiple virulence factors due to impaired translation efficiencies. A translation defect was supported by the observation that mutants lacking MnmE, which functions in the same tRNA modification pathway as GidA, phenocopied GidA deficiency. Mutants stimulated an identical cytokine response in cultured macrophages, with the exception of reduced levels of TNF-alpha and IL-23. Significantly, GidA- mutants were highly attenuated in the murine ulcer model of soft tissue infection. These characteristics suggest that GidA pathway tRNA modification mutants are attractive candidates for further evaluation as live attenuated strains.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.